MedTrace Logo

Efficacy and Acceptability of Two Lubricant Eye Drops

NCT00756678 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2011-10-31

Study results available
· View outcomes & findings →

Summary

Efficacy and acceptability of two new artificial tears following two weeks of treatment in patients with dry eye. Patients will be randomized to 1 of 2 treatments for 7 days then crossover to the alternate treatment for 7 days.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

Lubricant Eye Drops (Optive™)

1 drop in both eyes as needed for 7 days'

DRUG

Lubricating Eye Drops (blink® Tears)

1 drop in both eyes as needed for 7 days

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00756678 on ClinicalTrials.gov